Sarah A. O'Dowd - Jan 16, 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Director
Signature
/s/ Asif Ali, Attorney-in-Fact for Sarah A. O'Dowd
Stock symbol
PTGX
Transactions as of
Jan 16, 2023
Transactions value $
$0
Form type
4
Date filed
1/18/2023, 07:00 PM
Previous filing
May 27, 2022
Next filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +30K $0.00 30K Jan 16, 2023 Common Stock 30K $12.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 12 equal monthly installments following the date of grant.

Remarks:

Exhibit 24 - Power of Attorney